Health
Investigational Drug Stops Toxic Proteins Tied to Neurodegenerative Diseases – Mirage News
PHILADELPHIA — An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and…
PHILADELPHIA — An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein’s buildup and neurological decline associated with these disorders, suggests a pre-clinical study from researchers at Penn Medicine and Mayo Clinic. Results were published in Science Translational Medicine.
The work shows, for the first time, how toxic poly(GR) (glycine-arginine repeat) pro…
-
Business20 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News22 hours agoBroncos staffer who guided Mam through crash crisis admits to drink-driving
-
Noosa News23 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News16 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track